OPEN Return Rate
IPO$Sonnet BioTherapeutics(SONN.US) still needs a risk warning
This stock previously surged to $20 because it was to be used as a shell for crypto stock
After the merger it accounts for 1% following HYBE
Based on the merger value the average per share is $3.3 With this trading volume and turnover rate it's hard not to suspect market manipulation
Last time too many people got trapped and had to cut losses
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
